SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (959)12/2/1996 7:52:00 PM
From: John H. Farro   of 4342
 
Rick, these must be the two drugs that I mentioned a while back that were in phase I of trials. Of course, it is important to keep in mind that PRLN has not closed the deal to acquire EWH yet and it is possible the deal might not go through. I think whether PRLN decides to actually complete the deal will depend on how close they are to marketing a product by April. Remember, the two drugs that EWH are testing can be considered a bonus if this deal goes through. Kind of like having two extra lottery tickets thrown into the deal. But the main purpose for acquiring EWH would be to use EWH's position as a world leader in marketing Traditional Chinese Medicine in order to market AndroVir and AndroCar.

Robin M.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News